StockData
ANI Pharmaceuticals Inc logo

ANI Pharmaceuticals Inc (ANIP) stock

ANIPNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 14/3048% below fair value
$69.99−0.90 (-1.27%)

Close on Nov 17, 2026Market cap $1.61BP/E 14.9Yield –

ANI Pharmaceuticals pe ratio

The price-to-earnings ratio is the share price divided by diluted earnings per share over the trailing twelve months.

ANI Pharmaceuticals's pe ratio was 14.4× on Nov 11, 2026, against 52.1× a year earlier. Over the last 5 years it ranged from 14.4× to 173.7×, with a median of 60.6×.

PE Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2026Nov 11, 202614.4×−34.0
2025Dec 31, 202548.4×−0.5
2024Oct 31, 202448.9×−57.1
2023Dec 29, 2023106.0×+26.0
2020Apr 30, 202080.0×+34.3
2019Dec 31, 201945.7×−59.3
2018Jan 31, 2018104.9×+4.2
2017Dec 29, 2017100.7×+12.8
2016Dec 30, 201687.9×+72.3
2015Dec 31, 201515.6×–

More ANI Pharmaceuticals figures

See a number that looks wrong?